Filter posts

New Coalition to Raise Awareness of Antimicrobial Resistance Threat, Call for Urgent Solutions

The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced …

BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN

BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest …

Biotech Leaders Warn: Shortsighted Policies Threaten Miracle Breakthroughs

Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of …

Why Are Patients Facing Higher Costs When They Go to the Pharmacy?

BIO is out with a new whiteboard video that explores why more and more patients …

Experts Weigh In on the Dangers of Importing Foreign Price Controls

Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead …

Rare Disease Drug Development Increases but Challenges Remain

In a recent study published by Tufts University, researchers found that rare disease drug development …

Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right...

In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies …

The DISARM Act Can Help Fix the Broken Antibiotics Market

In a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly …

Buzz at BIO: John Hawkins, Author of Conscience and Courage

In his soon-to-be-released book Conscience and Courage, author John Hawkins reveals the philosophy, principles, methods, …

Buzz at BIO: Dr. Julie Gerberding, Merck

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access …